LLY vs VTRS
By Alex · Tickerpine
Eli Lilly and Company vs Viatris Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | VTRS |
|---|---|---|
| Price | $1,220.28 | $16.10 |
| Market cap | $1.09T | $18.49B |
| P/E ratio | 41.0 | — |
| ROE | 102.29% | -2.75% |
| Profit margin | 33.53% | -2.79% |
| Revenue growth | 47.70% | 4.90% |
| Dividend yield | 0.57% | 2.98% |
| Beta | 0.51 | 0.89 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs VTRS in plain English
- LLY is the bigger company — about 58.8× the market cap of VTRS.
- LLY earns a higher return on equity (102% vs -3%).
- LLY is growing revenue faster (48% vs 5%).
- VTRS has the higher dividend yield (2.98% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
VTRS return calculator
See what $1,000 in Viatris Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.